Median progression-free survival (PFS) and peak mean anti-Globo H (anti-GH) IgM and IgG of the subject groups with anti-GH IgM ≥1:320 and <1:320 within 4 weeks after vaccination
| Adagloxad simolenin/OBI-821 group with IgM level within first 4 weeks | |||
| <1:320 (n=161) | ≥1:320 (n=63) | P value | |
| Median PFS (month) | 7.3 | 11.1 | 0.1635* |
| Peak mean IgM | 68.8 | 746.6 | <0.0001† |
| Peak mean IgG | 85 | 222.6 | <0.0001 |
*Log-rank test
†t-test